Back
Cullinan Therapeutics Stock Price Chart
BREAKING: Elon Musk's Secret A.I. Project Set to Plunge Millions of Americans Into Poverty
Click here now to prepare yourself for what's around the corner
Buy
67
CGEM
Cullinan Therapeutics
Last Price:
28.49
Seasonality Move:
4.4%
7 Day Trial
ALL ACCESS PASS
$
7
NOW is the time to get in on this trillion-dollar megatrend
Get it here.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CGEM is experiencing selling pressure, which indicates risk of future bearish movement.
Cullinan Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.95 | Sell |
| 20-day SMA: | 21.95 | Buy |
| 50-day SMA: | 18.97 | Buy |
| 200-day SMA: | 12.86 | Buy |
| 8-day EMA: | 26.99 | Buy |
| 20-day EMA: | 23.55 | Buy |
| 50-day EMA: | 19.96 | Buy |
| 200-day EMA: | 14.67 | Buy |
Cullinan Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.14 | Buy |
| Relative Strength Index (14 RSI): | 71.62 | Buy |
| Chaikin Money Flow: | -890841 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.82 - 26.08) | Buy |
| Bollinger Bands (100): | (11.4 - 21.02) | Buy |
Cullinan Therapeutics Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Cullinan Therapeutics Stock
Is Cullinan Therapeutics Stock a Buy?
- Cullinan Therapeutics share price is 27.72 while CGEM 8-day simple moving average is 27.95, which is a Sell signal.
- The stock price of CGEM is 27.72 while Cullinan Therapeutics 20-day SMA is 21.95, which makes it a Buy.
- Cullinan Therapeutics 50-day simple moving average is 18.97 while CGEM share price is 27.72, making it a Buy technically.
- CGEM stock price is 27.72 and Cullinan Therapeutics 200-day simple moving average is 12.86, creating a Buy signal.
CGEM Technical Analysis vs Fundamental Analysis
Buy
67
Cullinan Therapeutics (CGEM)
is a Buy
Is Cullinan Therapeutics a Buy or a Sell?
-
Cullinan Therapeutics stock is rated a Buy
The current Cullinan Therapeutics [CGEM] share price is $27.72. The Score for CGEM is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
Cullinan Therapeutics Stock Info
Market Cap:
1.19B
Price in USD:
27.72
Share Volume:
1.03M
Cullinan Therapeutics 52-Week Range
52-Week High:
30.19
52-Week Low:
7.64
Buy
67
Cullinan Therapeutics (CGEM)
is a Buy
Cullinan Therapeutics Share Price Forecast
-
What is the Cullinan Therapeutics stock price today?
The Cullinan Therapeutics stock price is 27.72 USD today. -
Will CGEM stock go up or go down?
Cullinan Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Cullinan Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cullinan Therapeutics is not overvalued.
Is Cullinan Therapeutics Stock a Buy?
- Cullinan Therapeutics share price is 27.72 while CGEM 8-day exponential moving average is 26.99, which is a Buy signal.
- The stock price of CGEM is 27.72 while Cullinan Therapeutics 20-day EMA is 23.55, which makes it a Buy.
- Cullinan Therapeutics 50-day exponential moving average is 19.96 while CGEM share price is 27.72, making it a Buy technically.
- CGEM stock price is 27.72 and Cullinan Therapeutics 200-day simple moving average is 14.67, creating a Buy signal.
Fundamental Analysis of Cullinan Therapeutics
Is Cullinan Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.06 per share, an increase this year of $0.57 per share, and an increase next year of $0.23 per share.
Technical Analysis of Cullinan Therapeutics
Should I short Cullinan Therapeutics stock?
- CGEM Moving Average Covergence Divergence (MACD) indicator is 3.14, suggesting Cullinan Therapeutics is a Buy
- Cullinan Therapeutics Relative Strength Index (RSI) is 71.62, which suggest Cullinan Therapeutics is overbought
- The Bollinger Bands (25) for Cullinan Therapeutics is (15.82 - 26.08), which suggest Cullinan Therapeutics is a Buy
- The Bollinger Bands (100) for Cullinan Therapeutics is (11.4 - 21.02), which suggest Cullinan Therapeutics is a Buy
* Cullinan Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.